Significance of Isolated Reactive Treponemal Chemiluminescence Immunoassay Results
Open Access
- 6 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 207 (9), 1416-1423
- https://doi.org/10.1093/infdis/jis459
Abstract
Background. Isolated reactive serum treponemal chemiluminescence immunoassay (CIA) specimens cause clinical uncertainty. Methods. Sera were screened by CIA, and reactive samples underwent reflex testing with rapid plasma reagin (RPR), Treponema pallidum particle agglutination (TPPA), and fluorescent treponemal antibody absorption (FTA Abs) assays. Samples reactive only on the CIA were deemed “isolated” reactive CIA samples. We undertook detailed review of a subset of subjects with isolated reactive CIA specimens. Results. Of 28 261 specimens, 1171 (4.1%) were reactive on CIA, of which 133 (11.3%) had isolated CIA reactivity. Most subjects (66 of 82 [80.5%]) with isolated reactive CIA specimens were from high-prevalence populations. We found evidence of CIA, TPPA, and FTA Abs seroreversion. The median chemiluminescent signal-to-cutoff ratio was similar for isolated reactive CIA sera and sera that were reactive on either FTA Abs or TPPA assays (2.19 vs 2.32; P = .15) but lower than for sera reactive on both FTA Abs and TPPA assays (12.37; P < .001) or for sera reactive on RPR assays (25.53; P < .001). A total of 11 of 20 patients (55%) with an isolated reactive CIA specimen who underwent medical record review had previous or subsequent evidence of syphilis infection. Conclusions. Isolated reactive CIA specimens may represent true T. pallidum infection and may be found after seroreversion of traditional treponemal assays.Keywords
This publication has 17 references indexed in Scilit:
- Screening for Syphilis With the Treponemal Immunoassay: Analysis of Discordant Serology Results and Implications for Clinical ManagementThe Journal of Infectious Diseases, 2011
- NovelTreponema pallidumSerologic Tests: A Paradigm Shift in Syphilis Screening for the 21st CenturyClinical Infectious Diseases, 2010
- The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilisSexually Transmitted Infections, 2009
- Infectious syphilis in high-income settings in the 21st centuryThe Lancet Infectious Diseases, 2008
- Serological diagnosis of syphilis: comparison of the Trep-Chek IgG enzyme immunoassay with other screening and confirmatory testsFEMS Immunology & Medical Microbiology, 2007
- Performance of CAPTIA SelectSyph-G Enzyme-Linked Immunosorbent Assay in Syphilis Testing of a High-Risk Population: Analysis of Discordant ResultsJournal of Clinical Microbiology, 2007
- Syphilis and HIV: a dangerous combinationThe Lancet Infectious Diseases, 2004
- Investigation of isolated positive syphilis enzyme immunoassay (ICE Murex) resultsInternational Journal of STD & AIDS, 2002
- Primary and secondary syphilis, 20 years' experience. 3: Diagnosis, treatment, and follow up.Sexually Transmitted Infections, 1989
- Serodiagnosis of Syphilis by Enzyme-Linked Immunosorbent Assay with Purified Recombinant Treponema pallidum Antigen 4DThe Journal of Infectious Diseases, 1986